Role of gemfibrozil as an inhibitor of CYP2C8 and membrane transporters.
about
Effect of gemfibrozil or rifampicin on the pharmacokinetics of selexipag and its active metabolite in healthy subjects.A common missense variant of LILRB5 is associated with statin intolerance and myalgia.Implications of inter-correlation between hepatic CYP3A4-CYP2C8 enzymes for the evaluation of drug-drug interactions: a case study with repaglinide.Fibrates in the management of atherogenic dyslipidemia.Clopidogrel but Not Prasugrel Significantly Inhibits the CYP2C8-Mediated Metabolism of Montelukast in Humans.
P2860
Role of gemfibrozil as an inhibitor of CYP2C8 and membrane transporters.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Role of gemfibrozil as an inhibitor of CYP2C8 and membrane transporters.
@en
type
label
Role of gemfibrozil as an inhibitor of CYP2C8 and membrane transporters.
@en
prefLabel
Role of gemfibrozil as an inhibitor of CYP2C8 and membrane transporters.
@en
P2860
P50
P1476
Role of gemfibrozil as an inhibitor of CYP2C8 and membrane transporters
@en
P2093
Mikko Niemi
P2860
P356
10.1080/17425255.2016.1227791
P407
P577
2016-08-31T00:00:00Z